---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-21-004619"
form_type: "8-K"
ticker: "AGTX"
cik: "0001603345"
company_name: "Agentix Corp."
filed_at: "2021-07-14T23:59:59+00:00"
generated_at: "2026-06-30T05:25:12.427575+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Agentix corrects prior filing; enters merger to make Applied BioPharma wholly-owned sub

## Summary
- Corrects May 27, 2021 8-K to clarify Applied BioPharma was not then a wholly-owned subsidiary.
- Enters Merger Agreement (July 13, 2021) with AB Merger LLC to acquire Applied BioPharma for 1 share of common stock.
- Articles of Merger executed July 14, 2021, expected to be filed with Nevada Secretary of State on July 15, 2021.
- Upon consummation, Applied BioPharma will become a wholly-owned subsidiary of Agentix Corp.

## SEC filing metadata
- accession: 0001477932-21-004619
- form_type: 8-K
- ticker: AGTX
- cik: 0001603345
- company_name: Agentix Corp.
- filed_at: 2021-07-14T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1603345/000147793221004619/0001477932-21-004619-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1603345/000147793221004619/agtx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-21-004619
- JSON: https://secwatch.observer/filing/0001477932-21-004619.json
- Plain text: https://secwatch.observer/filing/0001477932-21-004619.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.